PJP Holdings — Invesco Pharmaceuticals ETF
All 34 reported holdings of Invesco Pharmaceuticals ETF (PJP) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Invesco Private Prime Fund | 12.06% | $40.18M |
| Pfizer Inc. | 5.21% | $17.37M |
| Johnson & Johnson | 4.95% | $16.48M |
| AbbVie Inc. | 4.90% | $16.33M |
| Amgen Inc. | 4.79% | $15.96M |
| Eli Lilly and Co. | 4.76% | $15.85M |
| Gilead Sciences, Inc. | 4.70% | $15.64M |
| Merck & Co., Inc. | 4.67% | $15.55M |
| Invesco Private Government Fund | 4.64% | $15.47M |
| Abbott Laboratories | 4.20% | $13.99M |
| Travere Therapeutics, Inc. | 4.00% | $13.33M |
| Corcept Therapeutics Inc. | 3.74% | $12.47M |
| Ligand Pharmaceuticals Inc. | 3.56% | $11.86M |
| United Therapeutics Corp. | 3.54% | $11.80M |
| Liquidia Corp. | 3.43% | $11.42M |
| Jazz Pharmaceuticals PLC | 3.43% | $11.42M |
| Harmony Biosciences Holdings, Inc. | 3.25% | $10.84M |
| Ocular Therapeutix, Inc. | 3.07% | $10.23M |
| ANI Pharmaceuticals, Inc. | 3.04% | $10.13M |
| Bristol-Myers Squibb Co. | 2.89% | $9.62M |
| Innoviva, Inc. | 2.88% | $9.60M |
| Biogen Inc. | 2.85% | $9.48M |
| Viatris Inc. | 2.73% | $9.09M |
| Regeneron Pharmaceuticals, Inc. | 2.68% | $8.94M |
| Supernus Pharmaceuticals, Inc. | 2.64% | $8.80M |
| Amneal Pharmaceuticals, Inc. | 2.58% | $8.58M |
| Tarsus Pharmaceuticals, Inc. | 2.49% | $8.29M |
| Prestige Consumer Healthcare Inc. | 2.40% | $8.00M |
| Perrigo Co. PLC | 2.38% | $7.92M |
| Amphastar Pharmaceuticals, Inc. | 2.33% | $7.76M |
| Collegium Pharmaceutical, Inc. | 2.19% | $7.30M |
| Invesco Government & Agency Portfolio | 0.05% | $162.34K |
| OmniAb, Inc. | 0.00% | $0 |
| OmniAb, Inc. | 0.00% | $0 |